Weight Loss with Tirzepatide
Tirzepatide is a weekly subcutaneous (under the skin) injection that can help manage weight loss in those with a body mass index (BMI) of 27 or greater who have at least one weight-related ailment or in patients with a BMI of 30 or greater.
Tirzepatide (Mounjaro, Zepbound) is a peptide therapy weight loss drug that is administered by injection. This particular treatment is effective in helping patients with type 2 diabetes manage their condition. At the same time, it can boost weight loss for patients with a high BMI who struggle to achieve their desired results with diet and exercise alone. The medication controls insulin levels, producing more when blood sugar levels rise. At the same time, it slows the movement of food in the stomach, allowing the patient who takes the injections to feel fuller, longer.
Tirzepatide is a GLP-1 (glucagon-like peptide-1) agonist that helps regulate appetite and food intake. Tirzepatide requires a prescription and is a once weekly injection that is given just under the skin with a gradually increasing dose. Clients can be instructed on how they can give these injections to themselves, by family members, or they can come to our clinic to get their injection.
At Alpha Wellness Lab, Jason will monitor your progress and help you determine how long your treatment plan will be. For substantial weight loss, the use of tirzepatide shall be combined with a healthy low calorie diet and exercise routine.
Tirzepatide Weight Loss Benefits
-
Reduced waist circumference
-
Decreased risk of heart disease
-
Improvement in systolic blood pressure
-
Improved lipid blood levels
-
Lower HbA1c (used to monitor diabetes)
-
Decreased inflammatory markers
-
Can improve PCOS (polycystic ovarian syndrome)
Tirzepatide may cause GI upset such as nausea, vomiting, diarrhea, constipation, and gas. These symptoms tend to resolved over time. The tirzepatide prescribed at Alpha Wellness Lab is compounded with B12 to reduce possible GI symptoms.
In research studies, patients lost 15-20 % of their bodyweight and inches from their waistline while taking tirzepatide.
​
Who should NOT take Tirzepatide
You should note take tirzepatide if you are pregnant, breastfeeding, or plan on becoming pregnant in the next few months. You should also not take tirzepatide if you have a history of pancreatitis, multiple endocrine neoplasia, or medullary thyroid carcinoma.